Allurion Technologies Inc (ALUR)
1.90
-0.21
(-9.95%)
USD |
NYSE |
May 15, 15:29
Allurion Technologies SG&A Expense (Quarterly): 26.10M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 26.10M |
September 30, 2023 | 32.93M |
June 30, 2023 | 16.68M |
March 31, 2023 | 17.17M |
Date | Value |
---|---|
December 31, 2022 | 19.66M |
September 30, 2022 | 19.51M |
June 30, 2022 | 13.95M |
March 31, 2022 | 12.65M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
12.65M
Minimum
Mar 2022
32.93M
Maximum
Sep 2023
19.83M
Average
18.34M
Median
SG&A Expense (Quarterly) Benchmarks
Outset Medical Inc | 32.49M |
Paragon 28 Inc | 54.22M |
Perspective Therapeutics Inc | 1.694M |
Xtant Medical Holdings Inc | 20.45M |
Asensus Surgical Inc | 7.773M |